ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,849, issued on Nov. 25, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).
"EGFR inhibitors for the treatment of cancer" was invented by Cosimo Dolente (Allschwil, Switzerland), Annick Goergler (Colmar, France), David Hewings (Basel, Switzerland), Georg Jaeschke (Basel, Switzerland), Bernd Kuhn (Reinach BL, Switzerland), Yvonne Alice Nagel (Basel, Switzerland), Christa Ulrike Obst-Sander (Reinach BL, Switzerland), Antonio Ricci (Biel-Benken, Switzerland), Daniel Rueher (Raedersdorf, France) and Sandra Steiner (Sursee, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The application relates to (106) specific heterocyclic compounds...